Genetic screening for familial hypercholesterolaemia
Parrella A, Mundy L, Hiller JE
Record ID 32007000179
English
Authors' recommendations:
It is likely that a family cascade screening program in Australia would increase public costs of drug therapy due to greater detection of familial hypercholesterolaemia (FH). However, successful treatment regimes have demonstrated cost-effectiveness and may have the potential to reduce the risk of cardiovascular disease (CVD) in patients who are currently asymptomatic.
Authors' methods:
Given the potential positive therapeutic benefits of identifying family members of familial hypercholesteraemia probands, HealthPACT recommended that a Horizon Scanning Report be conducted on this technology.
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Molecular Diagnostic Techniques
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.